<i>Eh</i> promotes the degradation of neddylated and unneddylated cullin-1/5. by Attinder Chadha (11414273)

Pacritinib effectively decreases BTIC viability and sphere forming capacity and has on-target activity on phospho-STAT3. by Katharine Victoria Jensen (4691530)

“…<p>(A) Pacritinib dramatically decreased cell viability in a dose dependent manner in eleven molecularly diverse patient-derived BTIC cultures with IC₅₀ values from 0.62 μM to 1.66 μM. …”

PAC-1 activation counteracts impaired NSCs under hypoglycaemic <i>milieu via</i> the PKA-dependent pathway. by Shiva Mansouri (2838086)

TSA administration decreases neuromuscular junction loss in <i>Smn^2B/-</i> mice. by Hong Liu (50694)

“…Note that whilst there is widespread NMJ pathology in vehicle treated mice, as evidence by full/partial denervation (white arrowhead/arrow respectively), NF accumulation (yellow arrow) and small, immature post-synaptic endplates, NMJs appear much more healthy in TSA treated mice, as evidenced by a decrease in denervation and NF accumulation, and an increase in post-synaptic size and maturity (scale bar = 50 µm). …”

Cullin-1/5 degradation requires Gal-lectin-mediated contact with macrophage. by Attinder Chadha (11414273)

Table S4 from Decreased Mitochondrial DNA Content Drives OXPHOS Dysregulation in Chromophobe Renal Cell Carcinoma by Yi Xiao (14944362)

Delayed expression kinetics of the <i>PHO5</i>, but not the <i>lacZ</i> gene under regulation of the <i>PHO5</i> promoter in <i>rrp6Δ</i> mutant cells. by Ana Novačić (8373573)

Current Monitoring in a Microchannel with Repeated Constrictions for Accurate Detection of Sample Location in Isotachophoresis by Merav Karsenty (1694221)

“…We demonstrate the use of the technique to deliver sample to a designated location in the channel with an accuracy as low as 50 μm. …”

Current Monitoring in a Microchannel with Repeated Constrictions for Accurate Detection of Sample Location in Isotachophoresis by Merav Karsenty (1694221)

“…We demonstrate the use of the technique to deliver sample to a designated location in the channel with an accuracy as low as 50 μm. …”

Current Monitoring in a Microchannel with Repeated Constrictions for Accurate Detection of Sample Location in Isotachophoresis by Merav Karsenty (1694221)

“…We demonstrate the use of the technique to deliver sample to a designated location in the channel with an accuracy as low as 50 μm. …”

RNS60 treatment of tMCAo mice decreased microglial activation in the CA3 region of the ipsilateral hippocampus. by Gloria Patricia Baena-Caldas (17721328)

VPA treated prostate cancer cells show decreased repair capacity and γ-H2AX clearance. by Sushant K. Kachhap (273170)

DPOAE responses are decreased one week after treatment with 8,000 mg/kg HPβCD. by Mark A. Crumling (107429)

Presence of <i>Klf4</i> promoter elements decreases the effects of enhancer E2 in reporter assays. by Jack B. Waite (19762178)

Decreased LysoTracker-positive vacuoles containing <i>S. aureus</i> in <i>PRIP</i>-DKO MEFs. by Kae Harada-Hada (568788)

Design and Synthesis of Novel sEH Inhibitors for the Treatment of Inflammatory Bowel Disease by Huashen Xu (13987046)

“…Especially, lead compounds <b>A1</b> and <b>A9</b> showed potent inhibitory activities against sEH (<b>A1</b> and <b>A9</b>; hsEH IC₅₀ = 0.1 nM, msEH IC₅₀ = 0.1 nM). …”

Design and Synthesis of Novel sEH Inhibitors for the Treatment of Inflammatory Bowel Disease by Huashen Xu (13987046)

“…Especially, lead compounds <b>A1</b> and <b>A9</b> showed potent inhibitory activities against sEH (<b>A1</b> and <b>A9</b>; hsEH IC₅₀ = 0.1 nM, msEH IC₅₀ = 0.1 nM). …”

Design and Synthesis of Novel sEH Inhibitors for the Treatment of Inflammatory Bowel Disease by Huashen Xu (13987046)

“…Especially, lead compounds <b>A1</b> and <b>A9</b> showed potent inhibitory activities against sEH (<b>A1</b> and <b>A9</b>; hsEH IC₅₀ = 0.1 nM, msEH IC₅₀ = 0.1 nM). …”

Design and Synthesis of Novel sEH Inhibitors for the Treatment of Inflammatory Bowel Disease by Huashen Xu (13987046)

“…Especially, lead compounds <b>A1</b> and <b>A9</b> showed potent inhibitory activities against sEH (<b>A1</b> and <b>A9</b>; hsEH IC₅₀ = 0.1 nM, msEH IC₅₀ = 0.1 nM). …”

ETHE1-p.Arg163Gln and p.Arg163Trp are folded but have decreased stability. by Bárbara J. Henriques (627180)